Insufficient scRNA-seq data for expression of CHRNA2 at single-cell level.
Insufficient scRNA-seq data for expression of CHRNA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 92% | 3391.43 | 226 / 245 | 99% | 96.09 | 498 / 502 |
| brain | 75% | 235.51 | 1990 / 2642 | 23% | 0.72 | 165 / 705 |
| adrenal gland | 73% | 109.72 | 189 / 258 | 16% | 1.72 | 36 / 230 |
| peripheral blood | 50% | 29.24 | 468 / 929 | 0% | 0 | 0 / 0 |
| lung | 42% | 21.41 | 244 / 578 | 1% | 0.02 | 7 / 1155 |
| skin | 37% | 24.40 | 672 / 1809 | 0% | 0.01 | 2 / 472 |
| breast | 29% | 89.47 | 133 / 459 | 3% | 0.13 | 38 / 1118 |
| spleen | 31% | 9.70 | 75 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 15% | 3.99 | 49 / 328 | 1% | 0.03 | 1 / 178 |
| thymus | 7% | 2.05 | 47 / 653 | 7% | 0.25 | 40 / 605 |
| liver | 4% | 2.38 | 10 / 226 | 1% | 0.02 | 3 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 1.04 | 2 / 45 |
| stomach | 3% | 0.67 | 9 / 359 | 1% | 0.05 | 2 / 286 |
| esophagus | 2% | 0.66 | 36 / 1445 | 1% | 0.01 | 1 / 183 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.15 | 2 / 80 |
| intestine | 2% | 0.56 | 18 / 966 | 0% | 0.01 | 2 / 527 |
| adipose | 2% | 0.94 | 27 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.15 | 4 / 504 |
| blood vessel | 1% | 0.68 | 8 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 1% | 0.56 | 1 / 180 | 0% | 0 | 0 / 430 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.01 | 5 / 901 |
| muscle | 0% | 0.11 | 2 / 803 | 0% | 0 | 0 / 0 |
| uterus | 0% | 0 | 0 / 170 | 0% | 0.00 | 1 / 459 |
| heart | 0% | 0.02 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051899 | Biological process | membrane depolarization |
| GO_0098828 | Biological process | modulation of inhibitory postsynaptic potential |
| GO_0060079 | Biological process | excitatory postsynaptic potential |
| GO_0007165 | Biological process | signal transduction |
| GO_0034220 | Biological process | monoatomic ion transmembrane transport |
| GO_0006811 | Biological process | monoatomic ion transport |
| GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
| GO_0035094 | Biological process | response to nicotine |
| GO_0071316 | Biological process | cellular response to nicotine |
| GO_0007271 | Biological process | synaptic transmission, cholinergic |
| GO_0120111 | Cellular component | neuron projection cytoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0043005 | Cellular component | neuron projection |
| GO_0045171 | Cellular component | intercellular bridge |
| GO_0045202 | Cellular component | synapse |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0005892 | Cellular component | acetylcholine-gated channel complex |
| GO_1901363 | Molecular function | heterocyclic compound binding |
| GO_0015464 | Molecular function | acetylcholine receptor activity |
| GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
| GO_0050997 | Molecular function | quaternary ammonium group binding |
| Gene name | CHRNA2 |
| Protein name | Neuronal acetylcholine receptor subunit alpha-2 Cholinergic receptor nicotinic alpha 2 subunit |
| Synonyms | |
| Description | FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . |
| Accessions | E5RHQ4 ENST00000518712.5 ENST00000524096.5 A0A0X1KG79 Q15822 ENST00000521921.5 E5RGT4 E5RK67 ENST00000520208.1 ENST00000240132.7 [Q15822-2] ENST00000523695.5 ENST00000407991.3 [Q15822-1] ENST00000520933.7 E5RGP6 ENST00000637241.1 E5RJ54 A0A1B0GVX5 |